Skip to content
Open access

Guidance for clinical variant classification in genes for spliceosomal small nuclear RNAs

Aug 2026 · medRxiv · 0 citations · 41 references
Medicine

TL;DR

The first guidance for clinical variant classification in snRNA genes is provided and it is anticipated that this will support routine screening and analysis of snRNA genes in clinical genetic testing.

Abstract

Background: Small nuclear RNAs (snRNAs) are RNA components of the major and minor spliceosomes that play a core role in splice-site recognition and control of the splicing process. Variants in genes that produce snRNAs are increasingly recognised as major contributors to rare disorders, including neurodevelopmental disorders (NDD) and retinal dystrophies (collectively termed RNUopathies, a subset of spliceosomopathies). Clinical interpretation of variants in snRNAs is, however, challenging and existing guidance to support clinical variant classification does not adequately capture the unique features of snRNAs that necessitate a bespoke approach. Methods: We quantified the elevated background mutation rate in snRNA genes using de novo variants from 12,007 trios and assessed mutation density in 76,215 genome sequenced individuals in gnomAD. We convened a panel of clinical, research, and industry scientists with wide-ranging expertise in clinical variant interpretation and classification and expert knowledge in snRNA genes to draft and refine a guidance document. Results: We detail important considerations for variant classification in snRNA genes. These include: the difficulties of variant identification which requires genome or targeted sequencing approaches, the large number of gene paralogs with high sequence identity that complicate read mapping and variant calling, and historical inaccuracies in snRNA gene annotation. Further we show a ~50-fold increase in de novo mutation rate in snRNA genes compared to intergenic sequence and discuss the implications of this for variant classification. We provide a set of specific recommendations for classifying variants in snRNA genes. Finally, we introduce RNUdb, an interactive web-based tool to support snRNA variant annotation and classification. Conclusions: We provide the first guidance for clinical variant classification in snRNA genes and anticipate that this will support routine screening and analysis of snRNA genes in clinical genetic testing.

Read PDF

Similar papers

Review Sep 2026

Splice-site variants in neurology: from molecular mechanisms to clinical interpretation — a focused review

This review synthesizes the molecular basis of splice-altering variants, current standards for their nomenclature and computational prediction, the practical strengths and limitations of RNA-level validation, and their contribution to epilepsy, hereditary neuropathy, ataxia, dystonia, mitochondrial disease, neuromuscul...

Nishanth Gowda, S. Harish · 0 citations
Open access Aug 2026

Analysis of spliceosome-related coding and noncoding genes and pseudogenes reveals novel candidates

By leveraging specialized approaches for prioritizing pseudogenes, combined with the PCG and snRNA analysis, the genes and variants expand the variant pathogenicity spectrum of spliceosomopathies and suggest variants for follow-up case series and future functional validation.

O. Messaoud, S. DiTroia, R. Tarawneh et al. · 0 citations
Open access Sep 2026

A cross-tissue splicing signature as a quantitative biomarker for ReNU syndrome

A robust RNA biomarker for T-loop ReNU syndrome for use in therapeutic development is defined, and a general framework for portable biomarker discovery in spliceopathies is illustrated.

Ruebena Dawes, A. Blakes, Theodora Markati et al. · 0 citations
Open access Aug 2026

Rapid minigene workflow for functional reclassification of splicing variants in hereditary cancer diagnostics

A streamlined minigene-based workflow for rapid functional evaluation of splicing variants and a robust and scalable framework for functional interpretation of splicing variants is developed, improving diagnostic resolution and supporting more informed clinical decision-making in hereditary cancer genetics.

Noemi Calandra, Elisabetta Mereu, P. Ogliara et al. · 0 citations
Aug 2026

RNA splicing evidence enables robust classification of BRCA1 exon 18 variants: Results from the ENIGMA consortium.

The Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) research consortium conducted a comprehensive study to characterize spliceogenic variants in BRCA1 exon 18, indicating the degree of splice perturbation required to impair BRCA1 function may depend on the nature of the resulting non-f...

Joanna Domènech-Vivó, Hélène Tubeuf, Romy L. S. Mesman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.